No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MEDP240621P320000
- 0.05
- -0.10-66.67%
15min DelayClose Jun 20 15:55 ET
0.35High0.05Low
0.35Open0.15Pre Close9 Volume35 Open Interest320.00Strike Price285.00Turnover154.73%IV20.14%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0044Delta0.0004Gamma8012.60Leverage Ratio-0.0500Theta-0.0001Rho-35.64Eff Leverage0.0029Vega
Intraday
- 5D
- Daily
News
Here's How Much You Would Have Made Owning Medpace Hldgs Stock In The Last 5 Years
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 32.97% on an annualized basis producing an average annual return of 46.08%. Currently, Medpace Hldgs has a market capit
Express News | Medpace Holdings Inc : Baird Raises Target Price to $456 From $454
Medpace Holdings (MEDP) Continues to Deliver Robust Financial Results
How Is The Market Feeling About Medpace Hldgs?
Medpace Hldgs's (NYSE:MEDP) short percent of float has fallen 4.16% since its last report. The company recently reported that it has 902 thousand shares sold short, which is 4.38% of all regular share
Medpace(MEDP.US) Officer Sells US$3.08 Million in Common Stock
$Medpace(MEDP.US)$ Officer BURWIG SUSAN E sold 7,681 shares of common stock on Jun 5, 2024 at an average price of $401.2 for a total value of $3.08 million.Source: Announcement What is statement of ch
Medpace Holdings Insider Sold Shares Worth $3,081,617, According to a Recent SEC Filing
Susan E Burwig, Executive Vice President, Operations, on June 05, 2024, sold 7,681 shares in Medpace Holdings (MEDP) for $3,081,617. Following the Form 4 filing with the SEC, Burwig has control over a
Comments
Investors expect Medpace Holdings to outperform the market, hence its high P/E ratio. Strong future growth anticipation makes investors pay more for the stock, supporting the share price.
The Price Is Right For Medpace Holdings, Inc. (NASDAQ:MEDP) 1
Medpace Holdings' robust conversion of profit to free cash flow is promising. Its underlying earnings potential may even surpass the statutory profit. Its earnings per share have seen a remarkable growth over the past three years.
1
Medpace Holdings' market sentiment remains steady, mirroring EPS growth. The stock's recent performance shows improvement, with a 90% shareholder return over the last year, surpassing the five-year TSR of 41% per year. The strong share price momentum suggests a closer look at the stock may be worthwhile.
Medpace's high P/E is backed by its forecast growth being higher than the wider market. Investors are quite confident in the company's future earnings and seem willing to pay more for the stock, suggesting a bullish outlook.
Insider selling at current price (US$274) is less worrying, but there were no purchases over the past year to boost confidence. A high level of insider ownership often implies interests of all shareholders are considered, though recent history of share sales triggers some hesitation.
Read more